HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

3rd Edition of

International Ophthalmology Conference

March 10-12, 2025 | Rome, Italy

IOC 2025

Role of Rho kinase Inhibitor in traumatic corneal decompensation

Speaker at International Ophthalmology Conference 2025 - Anita Mani
Military Hospital, India
Title : Role of Rho kinase Inhibitor in traumatic corneal decompensation

Abstract:

Purpose: To illustrate the role of Rho kinase inhibitor, ripasudil in the setting of post traumatic corneal decompensation.
Method: 32 years old male presented with blunt trauma to the left eye with corneal epithelial defect, stromal edema and Grade II hyphema. He was initially managed with topical antibiotics, steroids and cycloplegics and anti glaucoma medications with resolution of hyphema and healed epithelium. However there was persistence of corneal edema and a Rho kinase inhibitor was added to the treatment regimen on Day 5.
Results : There was rapid resolution of corneal edema and improvement in visual acuity within a week.
Conclusion :Ripasudil is a Rho kinase inhibitor which has a role in treatment of corneal endothelial decompensation in Fuch’s endothelial dystrophy and post cataract surgery corneal edema. This case highlights the adjuvant role of Ripasudil in a case of pot traumatic corneal decompensation.

Biography:

Dr Anita Mani studied MBBS and MS Ophthalmology at the prestigious Armed Forces Medical College. She has been practicing as an Ophthalmologist in the Indian Armed Forces since 2017 in various appointments at Kochi, Goa and Chennai. She has 3 case reports and 1 original article published in reputed international journals to her credit.

Watsapp